Selective AMPA receptor antagonist GYKI 52466 is effective in three animal models of anxiety

被引：1
|
作者：
Kapus, G [1 ]
Gacsályi, I [1 ]
Vegh, M [1 ]
Lévay, G [1 ]
机构：
[1] Egis Pharmaceut Ltd, Budapest, Hungary
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2003年 / 13卷
关键词：
D O I：
10.1016/S0924-977X(03)92141-9
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S362 / S362
页数：1
相关论文
共 50 条
  • [41] EFFECT OF THE NON-NMDA RECEPTOR ANTAGONIST GYKI-52466 ON THE MICRODIALYSATE AND TISSUE CONCENTRATIONS OF AMINO-ACIDS FOLLOWING TRANSIENT FOREBRAIN ISCHEMIA
    ARVIN, B
    LEKIEFFRE, D
    GRAHAM, JL
    MONCADA, C
    CHAPMAN, AG
    MELDRUM, BS
    JOURNAL OF NEUROCHEMISTRY, 1994, 62 (04) : 1458 - 1467
  • [42] Behavioural effects of the novel AMPA/GluR5 selective receptor antagonist NS1209 after systemic administration in animal models of experimental pain
    Blackburn-Munro, G
    Bomholt, SF
    Erichsen, HK
    NEUROPHARMACOLOGY, 2004, 47 (03) : 351 - 362
  • [43] Mechanism of Inhibition of the GluA1 AMPA Receptor Channel Opening by the 2,3-Benzodiazepine Compound GYKI 52466 and a N-Methyl-Carbamoyl Derivative
    Wu, Andrew
    Wang, Congzhou
    Niu, Li
    BIOCHEMISTRY, 2014, 53 (18) : 3033 - 3041
  • [44] Neuroprotective and anticonvulsant effects of EGIS-8332, a non-competitive AMPA receptor antagonist, in a range of animal models
    Gigler, G.
    Moricz, K.
    Agoston, M.
    Simo, A.
    Albert, M.
    Benedek, A.
    Kapus, G.
    Kertesz, S.
    Vegh, M.
    Barkoczy, J.
    Marko, B.
    Szabo, G.
    Matucz, E.
    Gacsalyi, I.
    Levay, G.
    Harsing, L. G., Jr.
    Szenasi, G.
    BRITISH JOURNAL OF PHARMACOLOGY, 2007, 152 (01) : 151 - 160
  • [45] Effective Suppression of Spasticity in Baclofen Tolerant Rats after Spinal or Systemic Treatment with the Selective AMPA Receptor Antagonist Tezampanel
    Oshiro, Masakatsu
    Hefferan, Michael Patrick
    Kakinohana, Osamu
    Marsala, Martin
    NEUROLOGY, 2009, 72 (11) : A367 - A368
  • [46] Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression
    Wesolowska, Anna
    Nikiforuk, Agnieszka
    NEUROPHARMACOLOGY, 2007, 52 (05) : 1274 - 1283
  • [47] Preclinical pharmacology of perampanel, a selective non-competitive AMPA receptor antagonist
    Rogawski, M. A.
    Hanada, T.
    ACTA NEUROLOGICA SCANDINAVICA, 2013, 127 : 19 - 24
  • [48] PHARMACOKINETICS OF PERAMPANEL, A HIGHLY SELECTIVE AMPA-TYPE GLUTAMATE RECEPTOR ANTAGONIST
    Templeton, David
    EPILEPSIA, 2009, 50 : 98 - 99
  • [49] CP-465,022, a selective noncompetitive AMPA receptor antagonist, blocks, AMPA receptors but is not neuroprotective in vivo
    Menniti, FS
    Buchan, AM
    Chenard, BL
    Critchett, DJ
    Ganong, AH
    Guanowsky, V
    Seymour, PA
    Welch, WM
    STROKE, 2003, 34 (01) : 171 - 176
  • [50] In rivo efficacy of the hepatically-selective glucocorticoid receptor antagonist A-348441 in animal models of diabetes
    Jacobson, P
    Wilcox, D
    Nguyen, P
    Von Geldern, T
    Zinker, B
    Mika, A
    Wang, JH
    Fung, S
    Ohman, L
    Fowlkes, D
    Opgenorth, T
    DIABETES, 2003, 52 : A341 - A341
12345